CA1109473A - Glaucine lactate salts - Google Patents

Glaucine lactate salts

Info

Publication number
CA1109473A
CA1109473A CA334,096A CA334096A CA1109473A CA 1109473 A CA1109473 A CA 1109473A CA 334096 A CA334096 A CA 334096A CA 1109473 A CA1109473 A CA 1109473A
Authority
CA
Canada
Prior art keywords
glaucine
lactate
percent
grams
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA334,096A
Other languages
English (en)
French (fr)
Inventor
Samuel S.M. Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Chemical Co
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Application granted granted Critical
Publication of CA1109473A publication Critical patent/CA1109473A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/18Ring systems of four or more rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
CA334,096A 1978-08-21 1979-08-20 Glaucine lactate salts Expired CA1109473A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93522078A 1978-08-21 1978-08-21
US935,220 1978-08-21

Publications (1)

Publication Number Publication Date
CA1109473A true CA1109473A (en) 1981-09-22

Family

ID=25466733

Family Applications (1)

Application Number Title Priority Date Filing Date
CA334,096A Expired CA1109473A (en) 1978-08-21 1979-08-20 Glaucine lactate salts

Country Status (22)

Country Link
JP (1) JPS5540672A (es)
AT (1) AT372374B (es)
AU (1) AU529554B2 (es)
BE (1) BE878355A (es)
CA (1) CA1109473A (es)
CH (1) CH641164A5 (es)
DE (1) DE2932833A1 (es)
DK (1) DK347279A (es)
ES (1) ES483500A1 (es)
FI (1) FI68812C (es)
FR (1) FR2434152A1 (es)
GB (1) GB2028323B (es)
GR (1) GR69851B (es)
IE (1) IE49057B1 (es)
IL (1) IL57934A (es)
IT (1) IT1123511B (es)
NL (1) NL7906216A (es)
NO (1) NO150001C (es)
NZ (1) NZ191171A (es)
PT (1) PT70097A (es)
SE (1) SE7906940L (es)
ZA (1) ZA794134B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150080467A1 (en) * 2008-06-04 2015-03-19 Rolf Kullgren Ab Vaginal suppository comprising lactic acid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2717001C2 (de) * 1977-04-18 1984-06-20 Karl O. Helm Ag, 2000 Hamburg Arzneimittel mit antithrombotischer Wirkung
DE2717062C2 (de) * 1977-04-18 1982-11-25 Karl O. Helm Ag, 2000 Hamburg Arzneimittel mit antitussiver Wirkung

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150080467A1 (en) * 2008-06-04 2015-03-19 Rolf Kullgren Ab Vaginal suppository comprising lactic acid
US10016358B2 (en) * 2008-06-04 2018-07-10 Rolf Kullgren Ab Vaginal suppository comprising lactic acid

Also Published As

Publication number Publication date
FI792357A (fi) 1980-02-22
ZA794134B (en) 1980-08-27
GR69851B (es) 1982-07-19
NZ191171A (en) 1984-05-31
GB2028323B (en) 1982-12-15
IT7924782A0 (it) 1979-07-31
FR2434152B1 (es) 1982-11-19
ATA558479A (de) 1983-02-15
FR2434152A1 (fr) 1980-03-21
PT70097A (en) 1979-09-01
CH641164A5 (fr) 1984-02-15
BE878355A (fr) 1980-02-21
NO792704L (no) 1980-02-22
NO150001B (no) 1984-04-24
GB2028323A (en) 1980-03-05
SE7906940L (sv) 1980-02-22
DK347279A (da) 1980-02-22
FI68812C (fi) 1985-11-11
JPS5540672A (en) 1980-03-22
DE2932833A1 (de) 1980-03-06
IE49057B1 (en) 1985-07-24
ES483500A1 (es) 1980-04-16
IT1123511B (it) 1986-04-30
NL7906216A (nl) 1980-02-25
IL57934A (en) 1983-12-30
NO150001C (no) 1984-08-01
FI68812B (fi) 1985-07-31
AU529554B2 (en) 1983-06-09
IE791597L (en) 1980-02-21
AU4935879A (en) 1981-02-26
IL57934A0 (en) 1979-11-30
AT372374B (de) 1983-09-26

Similar Documents

Publication Publication Date Title
CS227019B2 (en) Method of preparing (-)-n-methyl-3-(2-methylphenyloxy)-3-phenylpropylamine
HU201297B (en) Process for producing phenylcarbamates and pharmaceutical compositions comprising such compounds as active ingredient
US5240933A (en) 14-hydroxy-n-(2-methoxyethyl)-7,8-dihydromorphine and -norisomorphine, processes for the preparation thereof and the use thereof as pharmaceutical compositions
DK154293B (da) Analogifremgangsmaade til fremstilling af 2(3h)-indoloner
US20030114535A1 (en) Dextrochlorpheniramine tannate
CA1109473A (en) Glaucine lactate salts
US4265912A (en) Glaucine lactate salts
US4183939A (en) Glaucine analgesic method
US4279914A (en) Thrombocyte aggregation inhibiting composition and methods
US4315010A (en) Glaucine phosphate salts
KR840000056B1 (ko) 글라우신 락테이트 염의 제조방법
GB1588337A (en) Benzo-fused xanthenes thioxanthenes and dibenzoxepines and processes for their preparation
US9428516B1 (en) Crystalline forms of morphine sulfate
CA1117528A (en) Glaucine phosphate salts
US4370331A (en) L-Glaucine containing composition for cough relief
CA1108149A (en) D-glaucine phosphate salt
CA1331994C (en) (+)-1-¢(3,4,5-trimethoxy)-benzyloxymethyl!-1-phenyl-n,n- dimethyl-n-propylamine, process for preparing it and its therapeutical use
GB2061258A (en) Glaucine phosphate salts
US4764517A (en) 8α-(N,N-diethylsulfamoylamino)-6-n-propyl ergoline useful as a prolactin secretion inhibitor, anti-parkinson, anti-depressant agent
KR20020005055A (ko) 엔케이-1 수용체 길항물질로서 사용하기 위한 결정성(2-벤즈하이드릴-1-아자비사이클로[2.2.2]옥트-3-일)-(5-이소프로필-2-메톡시벤질)-아민 시트레이트의 다형태
CA1098035A (en) Anti-tussive and anti-thrombotic compositions containing tetrahydroxyaporphine or l-glaucine
US3073741A (en) Antitussive composition
US2917430A (en) Process of alleviating diarrhea with optical isomers of piperidyl methadone
KR840000057B1 (ko) 글라우신 포스페이트 염류의 제조방법
EP0002902A1 (en) Methylthiofluorothioxanthene derivative, its preparation and compositions containing it

Legal Events

Date Code Title Description
MKEX Expiry